Cordlife Group Ltd
SGX:P8A
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.12
0.455
|
Price Target |
|
We'll email you a reminder when the closing price reaches SGD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one P8A stock under the Base Case scenario is 0.263 SGD. Compared to the current market price of 0.155 SGD, Cordlife Group Ltd is Undervalued by 41%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Cordlife Group Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for P8A cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Cordlife Group Ltd
Balance Sheet Decomposition
Cordlife Group Ltd
Current Assets | 100.5m |
Cash & Short-Term Investments | 59.5m |
Receivables | 29.2m |
Other Current Assets | 11.7m |
Non-Current Assets | 123.8m |
Long-Term Investments | 13.5m |
PP&E | 16.4m |
Intangibles | 29.5m |
Other Non-Current Assets | 64.4m |
Current Liabilities | 32.7m |
Accounts Payable | 20.6m |
Other Current Liabilities | 12.1m |
Non-Current Liabilities | 68.9m |
Long-Term Debt | 990k |
Other Non-Current Liabilities | 67.9m |
Earnings Waterfall
Cordlife Group Ltd
Revenue
|
36.6m
SGD
|
Cost of Revenue
|
-17.1m
SGD
|
Gross Profit
|
19.6m
SGD
|
Operating Expenses
|
-36.5m
SGD
|
Operating Income
|
-16.9m
SGD
|
Other Expenses
|
5.9m
SGD
|
Net Income
|
-11.1m
SGD
|
Free Cash Flow Analysis
Cordlife Group Ltd
SGD | |
Free Cash Flow | SGD |
P8A Profitability Score
Profitability Due Diligence
Cordlife Group Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
Score
Cordlife Group Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
P8A Solvency Score
Solvency Due Diligence
Cordlife Group Ltd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Score
Cordlife Group Ltd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
P8A Price Targets Summary
Cordlife Group Ltd
Dividends
Current shareholder yield for P8A is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood and cord lining banking services. The Company’s segments include Banking and Diagnostic. The Banking segment comprises the banking of samples, such as cord blood, cord lining and cord tissue. The Diagnostic segment comprises Metascreen, which is a metabolic screening test specially designed for newborn babies, a non-invasive prenatal testing service, and Eyescreen, a noninvasive pediatric eye-screening service. The cord blood and cord lining are collected, processed and stored in the various laboratories in the regions that the Company operates in. The firm offers a range of diagnostics services for the family, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
Contact
IPO
Employees
Officers
The intrinsic value of one P8A stock under the Base Case scenario is 0.263 SGD.
Compared to the current market price of 0.155 SGD, Cordlife Group Ltd is Undervalued by 41%.